SCHEMBL4531401

SCHEMBL4531401

ClC1CCCOC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28421175 0.81
SCHEMBL1553372 0.81
Water SCHEMBL11361709 0.79
SCHEMBL29597118 0.77
Tetrahydrofuran SCHEMBL27896184 0.71 ALDH1A1 (0.47)
Fluoride SCHEMBL15271293 0.69
SCHEMBL19985099 0.69 ALDH1A1 (0.35)
SCHEMBL2077666 0.67
SCHEMBL14683300 0.67
SCHEMBL31121561 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-3931236-A Oxidation and dehydrohalogenation of halotetrahydropyrans PHILLIPS PETROLEUM COMPANY (US) 1976-01-06 US claimed
CN-115279847-B Active energy ray-curable ink and image recording method 富士胶片株式会社 2023-10-27 CN disclosed
US-20220098171-A1 5-(4-PYRIDYLOXY)PYRAZOLE COMPOUNDS SERVING AS TGF-ßR1 KINASE INHIBITOR JIANGSU AOSAIKANG PHARMACEUTICAL CO., LTD. (CN) 2022-03-31 US disclosed
EP-2638036-B1 COMPOUND FOR INCREASING KINASE ACTIVE AND APPLICATION THEREOF BETTA PHARMACEUTICALS CO LTD (CN) 2017-08-16 EP disclosed
EP-3083714-A1 CATALYST FOR THE POLYMERIZATION OF OLEFINS Basell Poliolefine Italia S.r.l. (IT) 2016-10-26 EP disclosed
US-9409900-B2 Compound for increasing kinase active and application thereof FUJIAN HAIXI PHARMACEUTICALS, INC. (CN) 2016-08-09 US disclosed
WO-2015091320-A1 CATALYST FOR THE POLYMERIZATION OF OLEFINS BASELL POLIOLEFINE ITALIA S.R.L. (IT) 2015-06-25 WO disclosed
EP-2638036-A1 COMPOUND FOR INCREASING KINASE ACTIVE AND APPLICATION THEREOF Zhejiang Beta Pharma Incorporation (CN) 2013-09-18 EP disclosed
US-20130225587-A1 COMPOUND FOR INCREASING KINASE ACTIVE AND APPLICATION THEREOF ZHEJIANG BETA PHARMA INCORPORATION (CN) 2013-08-29 US disclosed
WO-2012062210-A1 COMPOUND FOR INCREASING KINASE ACTIVE AND APPLICATION THEREOF ZHEJIANG BETA PHARMA INC. (CN) 2012-05-18 WO disclosed
CN-101282730-A Phosphate antigen salt of organic base and crystallization method thereof INNATE PHARMA (FR) 2008-10-08 CN disclosed
EP-1355886-A1 FUSED HETEROCYCLIC COMPOUNDS Takeda Chemical Industries, Ltd. (JP) 2003-10-29 EP disclosed
WO-2002062764-A1 FUSED HETEROCYCLIC COMPOUNDS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-08-15 WO disclosed
EP-0741702-A4 PROCESS FOR PREPARING 2-OXINDOLE-1-CARBOXAMIDES CATALYTICA INC (US) 1997-12-03 EP disclosed
EP-0741702-A1 PROCESS FOR PREPARING 2-OXINDOLE-1-CARBOXAMIDES CATALYTICA, INC. (US) 1996-11-13 EP disclosed
WO-1995020574-A1 PROCESS FOR PREPARING 2-OXINDOLE-1-CARBOXAMIDES CATALYTICA, INC. (US) 1995-08-03 WO disclosed
US-3931236-A Oxidation and dehydrohalogenation of halotetrahydropyrans PHILLIPS PETROLEUM COMPANY (US) 1976-01-06 US disclosed